Workflow
Longevity
icon
Search documents
X @The Economist
The Economist· 2025-08-24 15:20
“When we want to live longer, we can all do it together.” @devisridhar tells @alokjha that longevity is related to good policy, and government action. Find out more on “Babbage” https://t.co/FdqtI1eaRd ...
X @The Wall Street Journal
Health & Longevity - The study focuses on "super agers," individuals who maintain good health at 85 years and older [1] - Dr Eric Topol, a 70-year-old cardiologist, shares his personal health tips based on longevity research [1]
X @Tesla Owners Silicon Valley
RT Matteo Franceschetti (@m_franceschetti)BREAKING: We just raised $100M at @eightsleep to build the AI that finally fixes sleep.For decades, sleep has been passive. You lie down, close your eyes, and hope for the best. We’re changing that.Over 1B hours of biometric sleep data → distilled into fully autonomous AI that knows your body better than you do.We will do this in two ways:Step 1: Your personal Sleep Agent, running infinite nightly scenarios before they happen to deliver the most restorative sleep yo ...
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador
GlobeNewswire News Room· 2025-08-19 12:12
Core Viewpoint - Jupiter Neurosciences, Inc. has announced the addition of Chris Webber as the second brand ambassador for its new longevity supplement line, Nugevia™, which is based on clinical science and innovative performance-driven technology [1][3]. Company Overview - Jupiter Neurosciences is a clinical-stage pharmaceutical company focused on addressing neuroinflammation and promoting healthy aging through a dual-path strategy that includes advancing therapeutics for CNS disorders and entering the consumer longevity market with Nugevia™ [7]. - The company’s proprietary JOTROL™ platform enhances the bioavailability of resveratrol, which is the foundation for both its therapeutic pipeline and the Nugevia™ product line [10]. Product Details - Nugevia™ features three initial formulations—GLO, MND, and PWR—designed to support cellular resilience through synergistic ingredients optimized for absorption via the JOTROL™ system [4]. - The Nugevia™ brand aims to tap into the rapidly growing longevity market, projected to reach $8 trillion by 2030, creating a revenue stream to support ongoing clinical development and enhance long-term shareholder value [5][6]. Scientific Validation - JOTROL™ has demonstrated over nine times higher bioavailability compared to traditional resveratrol products, as evidenced by a Phase I study published in reputable journals [9]. - The technology aims to provide pharmaceutical-grade bioavailability in the wellness space, targeting cognitive health, skin vitality, and cellular energy [10].
X @Forbes
Forbes· 2025-08-19 06:10
Longer Leash On Life: Inside The Dog Longevity Startup https://t.co/Q2C4MvCF38 https://t.co/hIrj71I4KA ...
X @The Wall Street Journal
Health & Longevity - The study focuses on "super agers" who maintain health at 85 years and above [1] - Dr Eric Topol, a 70-year-old cardiologist, shares longevity tips [1] - The advice includes daily habits for healthy aging [1]
X @The Wall Street Journal
Dr. Eric Topol’s longevity work identified daily habits to follow in a study of “super agers” who are healthy at ages 85 and above."I am taking my own advice," says Dr. Eric Topol, a 70-year-old cardiologist.He shares the tips that he follows: 🔗 https://t.co/m4a3jIaSrG https://t.co/MFrqYAMGf3 ...
X @Forbes
Forbes· 2025-08-15 06:10
Industry Focus - The article discusses a startup focused on dog longevity [1] Company Overview - The company is working on extending the lifespan of dogs [1]
X @Forbes
Forbes· 2025-08-14 09:30
Company Overview - Celine Halioua's company has raised $135 million to develop canine longevity pills [1] Product Development - The company anticipates receiving its first conditional approval from the FDA next year for its canine longevity pills [1] Financial Highlights - The company has secured $135 million (135 million 美元) in funding from top investors [1]
X @Forbes
Forbes· 2025-08-14 03:30
Company Overview - Loyal 公司致力于研发延长犬类寿命的药物 [1] - Loyal 公司创始人 Celine Halioua 已经从顶级投资者那里筹集了 135 million 美元 [1] Funding - Loyal 公司已获得 135 million 美元的投资,用于开发犬类长寿药丸 [1]